Recent Highlights
All Stories for Covid 19 Vaccine Trials
UK investigates two adverse reactions to Pfizer jab, says people with history of serious allergic reactions shouldn't get inoculated
• 4 years agoProfessor Stephen Powis, national medical director for the National Health Service in England, said the condition of the two people who received the vaccine are recovering well
Germany COVID-19 tally rises to 10 lakh as second wave hits country; doubts emerge over vaccine
• 4 years agoThe number of COVID-19 patients in intensive care nationwide has soared from just over 360 in early October to more than 3,500 last week
Vaccine messaging faces unprecedented test with COVID-19 – success of a vaccine hinges on it
Jillian Kramer • 4 years agoIn the past, vaccine messaging has drawn on anti-polarization strategies to try building consensus around contentious issues.
AstraZeneca resumes UK trials for COVID-19 vaccine days after single recipient shows 'adverse reaction'
• 4 years agoThe trials for the coronavirus vaccine candidate, AZD1222, resumed in the UK following confirmation by the MHRA that it was safe to do so, AstraZeneca said in a statement
Uncertainty over long-term immune response has implications for efficacy of COVID-19 vaccine, say experts
• 5 years agoIn an editorial in the ICMR's, Indian Journal of Medical Research, experts also said that continued use of masks and other measures may be advocated if evidence shows a possible role of asymptomatic persons in COVID-19 transmission
Elderly, ethnic minority volunteers in COVID-19 vaccine trials vital for its success, expert says
• 5 years agoIt will be impossible to tell how well a vaccine works without recruiting a diverse range of volunteers in trials, a physician has said.
Moderna's COVID-19 vaccine helped monkeys make full recovery after SARS-CoV-2 infection
• 5 years agoWhile the findings don't guarantee the vaccine will perform equally well in people, the results are considered encouraging.
Moderna, Pfizer kick off late-stage COVID-19 vaccine trials; distribution in US by end-2020 a 'stretch goal'
• 5 years agoModerna said it could deliver some 500 million doses a year, and possibly up to 1 billion doses per year, starting in 2021.
Regeneron begins phase III trials of REGN-COV2; here's how antibody cocktail can help COVID-19 patients
Myupchar • 5 years agoCurrently, the antibody cocktail, developed by researchers at the University of Maryland School of Medicine and Regeneron, is in the phase 2 treatment trials stage
Indian pharma well-placed to develop, manufacture COVID-19 vaccine; but it must guard against rushing trials
Manasic • 5 years agoSome experts told Firstpost that the government is willing to fast-track regulation, which is a risk they are willing to take, after completing "due protocols to check the safety of the drug"